We are live on ! Find out more
TTNP

Titan Pharmaceuticals
TTNP

Delisted

TTNP was delisted on the 1st of October, 2025.

Back to rankings

Fund managers haven’t disclosed any holdings of TTNP yet.

TTNP Hedge Fund Activity: Q1 2026 in Review

6 of the 8,128 institutional investors tracked by Wall St. Rank reported a position in Titan Pharmaceuticals (TTNP) for Q1 2026, worth a combined $130 — down 16% from $154 a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new TTNP positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Bogart Wealth LLC, opening a new position worth an estimated $1.

  • 6 institutional investors held Titan Pharmaceuticals (TTNP) as of Q1 2026, up from 4 in Q4 2025.
  • Funds reported $130 of Titan Pharmaceuticals stock for Q1 2026, down 16% quarter-over-quarter.
  • 2 funds opened new Titan Pharmaceuticals positions in Q1 2026 and 0 closed out, a net change of +2 holders.
  • The largest Titan Pharmaceuticals buyer in Q1 2026 was Bogart Wealth LLC, an estimated $1 added.

Based on aggregated 13F filings for Q1 2026.